Related Experiment Video
Updated: Aug 5, 2025
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples,
Fiona O'Neill1, Taylor-Jade Allen-Coyle1,2, Sandra Roche1
1National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.
Abstract:
Herein, we describe the global comparison of miRNAs in human pancreatic cancer tumors, adjacent normal tissue, and matched patient-derived xenograft models using microarray screening. RNA was extracted from seven tumor, five adjacent normal, and eight FI PDX tumor samples and analyzed by Affymetrix GeneChip miRNA 4.0 array. A transcriptome analysis console (TAC) was used to generate comparative lists of up- and downregulated miRNAs for the comparisons, tumor vs. normal and F1 PDX vs. tumor. Particular attention was paid to miRNAs that were changed in the same direction in both comparisons. We identified the involvement in pancreatic tumor tissue of several miRNAs, including miR4534, miR3154, and miR4742, not previously highlighted as being involved in this type of cancer. Investigation in the parallel mRNA and protein lists from the same samples allowed the elimination of proteins where altered expression correlated with corresponding mRNA levels and was thus less likely to be miRNA regulated. Using the remaining differential expression protein lists for proteins predicted to be targeted for differentially expressed miRNA on our list, we were able to tentatively ascribe specific protein changes to individual miRNA. Particularly interesting target proteins for miRs 615-3p, 2467-3p, 4742-5p, 509-5p, and 605-3p were identified. Prominent among the protein targets are enzymes involved in aldehyde metabolism and membrane transport and trafficking. These results may help to uncover vulnerabilities that could enable novel approaches to treating pancreatic cancer.
Insights
This study compared microRNAs (miRNAs) in pancreatic cancer, normal tissue, and patient-derived xenografts. Novel miRNAs involved in pancreatic cancer were identified, offering potential new therapeutic targets.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- Understanding miRNA expression profiles in pancreatic cancer is vital for identifying therapeutic targets.
Purpose of the Study:
- To globally compare miRNA expression in human pancreatic cancer, adjacent normal tissue, and patient-derived xenograft (PDX) models.
- To identify novel miRNAs and their protein targets involved in pancreatic tumorigenesis.
- To explore potential therapeutic vulnerabilities in pancreatic cancer based on miRNA-protein interactions.
Main Methods:
- Microarray screening (Affymetrix GeneChip miRNA 4.0 array) of RNA from human pancreatic tumors, adjacent normal tissue, and F1 PDX tumors.
- Transcriptome analysis console (TAC) for comparative analysis of up- and downregulated miRNAs.
- Parallel analysis of mRNA and protein expression to identify miRNA-regulated proteins.
Main Results:
- Identified several miRNAs, including miR4534, miR3154, and miR4742, not previously associated with pancreatic cancer.
- Correlated differential miRNA expression with protein level changes, identifying potential miRNA targets.
- Highlighted specific protein targets, including enzymes in aldehyde metabolism and membrane transport, regulated by miRNAs such as miR-615-3p and miR-4742-5p.
Conclusions:
- This global miRNA comparison reveals novel players in pancreatic cancer.
- Identified specific miRNA-protein interactions that may represent vulnerabilities for novel therapeutic strategies.
- The findings provide a foundation for developing new treatments targeting miRNA pathways in pancreatic cancer.
